Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of 2 or 3 Doses of Rotarix in Healthy Infants
NCT00241644Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Primary completion
- Jun 2008
- Modality
- Live Attenuated Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral in rotavirus gastroenteritis, sponsored by GSK. Started Oct 2005; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00241644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241644.